In colorectal surgery, risk for blood clots appears higher with open method versus laparoscopy

The risk of developing venous thromboembolism (VTE) may be nearly twice as high for patients undergoing open surgery for colorectal problems, versus those undergoing laparoscopic colorectal (LC) resections, according to a report in the June issue of Archives of Surgery.

Venous thromboembolism (the formation of in the ) occurs in up to 25 percent of patients who undergo surgery without specific steps taken to prevent the condition, according to background information in the article. The authors note that colorectal surgery in particular carries a high risk for VTE. They also point out that prior research in a few common gastrointestinal procedures suggests that laparoscopic surgery is associated with fewer cases of VTE. "An improved knowledge of the risk factors in the development of VTE after LC compared with open colorectal (OC) resection," they write, "may help guide surgeons' selection of appropriate thromboprophylaxis in patients undergoing LC surgery."

Brian Buchberg, M.D., and colleagues from University of California–Irvine Medical Center, Orange, compared the risk of VTE procedures by examining the National Inpatient Sample database. Between January 2002 and December 2006, in the United States, 149,304 patients underwent elective colectomy. surgeries were performed in 5.3 percent of the total (7,848).

Among patients undergoing elective colectomies, VTE occurred in 1.4 percent (2,102). Sixty-five of those cases were in the LC group, versus 2,036 in the OC group, a significant difference. When the researchers analyzed the sample to stratify patients by risk factors, the odds of developing VTE were nearly twice as high in the OC group, compared with the LC group.

The authors note that their results appear to reflect the odds of OC-associated VTE that have been seen in other gastrointestinal surgical procedures. The apparent disparity between the methods leads them to "call into question whether we should be using the same risk factors and stratification for LC procedures as we do for OC procedures because certain for VTE in a patient undergoing OC surgery do not seem to portend an increased risk of VTE in the same patient undergoing LC surgery," they write. "These study findings may be used by surgeons to more accurately assess a patient's risk for perioperative VTE as well as to select appropriate thromboprophylaxis in patients undergoing LC surgery."

More information: Arch Surg. 2011;146[6]:739-743.

add to favorites email to friend print save as pdf

Related Stories

Risk of blood clots in veins hereditary

May 31, 2011

Venous thromboembolism (VTE) is the third most common type of cardiovascular disease after coronary heart disease and stroke. Researchers at the Centre for Primary Health Care Research in Malmo have mapped the significance ...

Recommended for you

Hormonal therapy for transsexualism safe and effective

11 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

15 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Getting enough sleep could help prevent type 2 diabetes

Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute (LA BioMed) research findings presented ...

Aspirin may fight cancer by slowing DNA damage

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...